Rhythm Biotherapeutics Revenue

Biotechnology Research • Ottawa, Ontario, Canada • 1-10 Employees

Rhythm Biotherapeutics revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$235,000

Key Contacts at Rhythm Biotherapeutics

Darryl Davis

Chief Executive Officer , Founder Chief Executive Officer And Founder

Darryl Davis

Chief Executive Officer

Company overview

Headquarters	40 Ruskin Street, Ottawa, Ontario K1Y 4W7 , CA
Website	rthm.bio
NAICS	541714
Founded	2022
Employees	1-10
Socials

About Rhythm Biotherapeutics

Rhythm Biotherapeutics Inc. (RBI) is a pre-clinical spinout of the University of Ottawa Heart Institute, founded in November 2022 by Darryl Davis, a cardiac electrophysiologist pioneering novel therapies to prevent and cure atrial fibrillation (AF). The company has developed a patent pending exosome therapy that, in animal studies, has proven to effectively prevent postoperative atrial fibrillation (POAF). RBI’s therapy uniquely addresses atrial inflammation and fibrosis, the fundamental physiological mechanism driving POAF. RBI is currently seeking investors who will accelerate achieving its next milestones. The obtainable market in North America and Europe for POAF therapy is over US$2B per year and growing.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Founder/Owner

Employees by Department

Rhythm Biotherapeutics has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Rhythm Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-02-01	10	$235,000
2025-01-03	9	N/A

Funding Insights

$235,000

Total funding amount

Number of funding rounds

Rhythm Biotherapeutics Tech Stack

Discover the technologies and tools that power Rhythm Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Frequently asked questions

Rhythm Biotherapeutics is located in Ottawa, Ontario, CA.

Rhythm Biotherapeutics generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Rhythm Biotherapeutics has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Rhythm Biotherapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Rhythm Biotherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Rhythm Biotherapeutics has raised a total of $235,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Rhythm Biotherapeutics

Darryl Davis

Chief Executive Officer , Founder Chief Executive Officer And Founder

Darryl Davis

Chief Executive Officer

4.8

40,000 users